Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Flu Season Appears `Typical' as U.S. Pushes Shots for All Ages
Bloomberg
Thu, 10/7/10 - 01:26 pm
Tags:
flu vaccine, United States, influenza, Sanofi, AstraZeneca, Novartis
Novartis to pay Gilenya patients' bills
Fierce Pharma
Thu, 10/7/10 - 11:52 am
Tags:
Novartis, Gilenya, MS, multiple sclerosis
Novartis, Synthetic Genomics in flu vaccine deal
Marketwatch
Thu, 10/7/10 - 08:08 am
Tags:
vaccines, Synthetic Genomics, Novartis, flu vaccine
Novartis Gilenya Launch: The Importance of Health Care Reform
InVivo
Wed, 10/6/10 - 10:11 am
Tags:
healthcare reform, Gilenya, Novartis, MS, multiple sclerosis
Small Biotech Partnering With Big Pharma for Major Projects
Minyanville
Tue, 10/5/10 - 06:51 pm
Tags:
partnerships, Human Genome Sciences, Zalbin, Novartis, Benlysta, GSK
Big Pharma behaving badly: A timeline of settlements
Fierce Pharma
Tue, 10/5/10 - 11:09 am
Tags:
settlements, Novartis, Forest Labs, Allergan, Elan, JNJ, AstraZeneca, Abbott Laboratories, Eli Lilly, Merck, GSK, Pfizer, Sanofi
Novartis Discontinues Two Drugs
TheStreet.com
Tue, 10/5/10 - 07:03 am
Tags:
Novartis, Human Genome Sciences, hepatitis C, antifungals, Mycograb
Here We Go Again: Novartis Fined for Off-Label Marketing
Seeking Alpha
Sun, 10/3/10 - 12:22 pm
Tags:
Novartis, off label
Novartis Whistleblower Speaks: ‘We Wasted Money’
Pharmalot
Fri, 10/1/10 - 12:43 pm
Tags:
Novartis, whistleblowers, off-label
Sanofi, Merck Said to Ready Sale of $1 Billion of Animal-Health Operations
Bloomberg
Fri, 10/1/10 - 10:11 am
Tags:
Merck, Sanofi, animal health, M&A, Pfizer, Bayer, Boehringer Ingelheim, Eli Lilly, Novartis
Novartis to pay $422.5 million settlement
Marketwatch
Thu, 09/30/10 - 03:46 pm
Tags:
Novartis, settlements, off-label, Trileptal, kickbacks
Odds Increase for Approval of Incyte's Myelofibrosis Drug
Seeking Alpha
Wed, 09/29/10 - 11:40 am
Tags:
Incyte, myelofibrosis, Novartis
The most (and least) efficient Big Pharma companies
Fierce Pharma
Tue, 09/28/10 - 11:54 am
Tags:
Roche, Bristol-Myers Squibb, Eli Lilly, JNJ, GSK, AstraZeneca, Novartis, Pfizer, Abbott Laboratories, Sanofi, Merck, Bayer
Better Buy: Ariad Pharmaceuticals or Corcept Therapeutics?
Motley Fool
Mon, 09/27/10 - 05:40 pm
Tags:
Ariad Pharmaceuticals, Corcept Therapeutics, ridaforolimus, Merck, Cushing's disease, Corlux, Novartis
From Cicada Fungus To MS Drug: How Big Will Novartis’ New Pill Be?
Forbes
Mon, 09/27/10 - 11:59 am
Tags:
Novartis, MS, multiple sclerosis, Gilenya
A Busy Week for Multiple Sclerosis News
Seeking Alpha
Sun, 09/26/10 - 12:24 pm
Tags:
Novartis, Merck KGaA, Gilenya, multiple sclerosis, cladribine, Biogen Idec, Bayer, Teva Pharmaceuticals
Novartis International AG: Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden for cystic fibrosis patients
Reuters
Fri, 09/24/10 - 12:19 pm
Tags:
Novartis, TOBI Podhaler, cystic fibrosis
Novartis Hid Health Risks of Bone Drugs, Lawyer Tells Jury in New Jersey
Bloomberg
Fri, 09/24/10 - 11:44 am
Tags:
Novartis, Zometa, Aredia
Novartis deal over, Alnylam cuts staff
Bizjournals.com
Fri, 09/24/10 - 11:16 am
Tags:
Novartis, Alnylam, layoffs, RNAi
Novartis to Sell U.S. Rights to Enablex
TheStreet.com
Fri, 09/24/10 - 09:58 am
Tags:
Novartis, Enablex, Warner Chilcott, overactive bladder

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.